BDX Quantitative Stock Analysis

Validea's guru fundamental report rates Becton Dickinson (BDX) at 54% using its Peter Lynch-based P/E/Growth Investor model, which seeks stocks with reasonable price relative to earnings growth and strong balance sheets. While the large-cap medical equipment firm passed criteria for P/E/Growth ratio and total debt/equity, it failed on sales & P/E ratio and EPS growth rate. This score falls significantly short of the 80% threshold typically indicating strategic interest, suggesting BDX does not currently meet the robust criteria for a strong endorsement from this specific value-oriented guru strategy.

Analysis

Becton Dickinson and Co. (BDX) receives a lukewarm assessment from Validea's P/E/Growth Investor model, which is based on Peter Lynch's strategy, scoring just 54%. This is significantly below the 80% threshold that would typically indicate strategic interest from the model. The analysis reveals a mixed fundamental picture for the large-cap medical equipment firm. On the positive side, BDX passes on its P/E/Growth ratio, inventory-to-sales, and total debt/equity ratio, suggesting reasonable valuation relative to growth, efficient inventory management, and a healthy balance sheet. However, these strengths are counteracted by critical failures in the model's criteria for EPS growth rate and the sales-to-P/E ratio. These failures directly challenge the company's profile as a compelling growth investment under this specific framework. Furthermore, neutral ratings on free cash flow and net cash position do little to bolster the investment case, indicating that while BDX possesses some stable financial characteristics, it currently lacks the robust growth metrics required to earn a strong endorsement from this quantitative screen.

Key Decisions for Investors

• Investors employing a 'growth at a reasonable price' (GARP) strategy, similar to Peter Lynch's, should exercise caution, as the model explicitly flags BDX's failure on the critical EPS growth rate criterion.
• The positive ratings on debt-to-equity and inventory management may appeal to more conservative or value-focused investors, but they must weigh these balance sheet strengths against the noted lack of top-line and earnings momentum.
• Given the overall low score of 54%, this report suggests that BDX is not a compelling buy based on this model's criteria; further due diligence on the drivers of future earnings and sales growth is warranted before initiating or adding to a position.